BB BIOTECH AG/ CH0038389992 /
6/28/2019 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
58.80EUR | - | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 2.3 bill.EUR | - | - |
Assets
2011 US GAAP in mill. CHF |
2012 US GAAP in mill. CHF |
2013 US GAAP in mill. CHF |
2014 US GAAP in mill. CHF |
2015 US GAAP in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | - | - | - | - | - | ||||||
Intangible Assets | - | - | - | - | - | ||||||
Long-Term Investments | 0.0000 | 9.6000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | 0.0000 | 10.8000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | - | - | - | - | - | ||||||
Cash and Cash Equivalents | 31.6000 | 18.9000 | 43.7000 | 9 | 21.1000 | ||||||
Current Assets | 1,151.6000 | 1,363.1000 | 2,210.9000 | 3,532.8000 | 4,143.7000 | ||||||
Total Assets | 1,151.6000 | 1,373.9000 | 2,210.9000 | 3,532.8000 | 4,143.7000 |
Liabilities
2011 US GAAP in mill. CHF |
2012 US GAAP in mill. CHF |
2013 US GAAP in mill. CHF |
2014 US GAAP in mill. CHF |
2015 US GAAP in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | - | - | - | - | - | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 148.7000 | 138.5000 | 90.7000 | 36.7000 | 161.2000 | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 149.9000 | 139.9000 | 92 | 40.3000 | 165.5000 | ||||||
Share Capital | - | - | - | - | - | ||||||
Total Equity | 1,001.7000 | 1,234 | 2,118.9000 | 3,492.5000 | 3,978.2000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 1,151.6000 | 1,373.9000 | 2,210.9000 | 3,532.8000 | 4,143.7000 |
Income Statement
2011 US GAAP in mill. CHF |
2012 US GAAP in mill. CHF |
2013 US GAAP in mill. CHF |
2014 US GAAP in mill. CHF |
2015 US GAAP in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 4.9000 | 392 | 950.9000 | 1,499.4000 | 697.9000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -65.1000 | 368.1000 | 932 | 1,470.2000 | 652.9000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -65.1000 | 368.1000 | 931.8000 | 1,470.2000 | 652.9000 | ||||||
Income Taxes | .1000 | .3000 | .1000 | .1000 | .0800 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | -65.1000 | 367.8000 | 931.8000 | 1,470.1000 | 652.8000 |
Per Share
Cash Flow
2011 US GAAP in mill. CHF |
2012 US GAAP in mill. CHF |
2013 US GAAP in mill. CHF |
2014 US GAAP in mill. CHF |
2015 US GAAP in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 169.5000 | 134.7000 | 117.1000 | 121.7000 | 52.4000 | ||||||
Cash Flow from Investing Activities | - | - | - | - | - | ||||||
Cash Flow from Financing | -161.3000 | -147 | -92.6000 | -157.3000 | -39 | ||||||
Decrease / Increase in Cash | 8.2000 | -12.8000 | 24.8000 | -34.7000 | 12.1000 | ||||||
Employees | - | - | - | - | - |